X4 Pharmaceuticals (XFOR) Accumulated Depreciation & Amortization (2018 - 2025)
Historic Accumulated Depreciation & Amortization for X4 Pharmaceuticals (XFOR) over the last 8 years, with Q2 2025 value amounting to $831000.0.
- X4 Pharmaceuticals' Accumulated Depreciation & Amortization rose 22460.94% to $831000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $831000.0, marking a year-over-year increase of 22460.94%. This contributed to the annual value of $796000.0 for FY2024, which is 8997.61% up from last year.
- X4 Pharmaceuticals' Accumulated Depreciation & Amortization amounted to $831000.0 in Q2 2025, which was up 22460.94% from $476000.0 recorded in Q1 2025.
- X4 Pharmaceuticals' 5-year Accumulated Depreciation & Amortization high stood at $831000.0 for Q2 2025, and its period low was $62000.0 during Q1 2024.
- Over the past 5 years, X4 Pharmaceuticals' median Accumulated Depreciation & Amortization value was $362000.0 (recorded in 2021), while the average stood at $367055.6.
- In the last 5 years, X4 Pharmaceuticals' Accumulated Depreciation & Amortization tumbled by 5118.11% in 2024 and then surged by 66774.19% in 2025.
- Over the past 5 years, X4 Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $499000.0 in 2021, then grew by 2.81% to $513000.0 in 2022, then fell by 18.32% to $419000.0 in 2023, then surged by 89.98% to $796000.0 in 2024, then grew by 4.4% to $831000.0 in 2025.
- Its Accumulated Depreciation & Amortization stands at $831000.0 for Q2 2025, versus $476000.0 for Q1 2025 and $796000.0 for Q4 2024.